FABP1 and metabolic dysfunction-associated steatotic liver disease: Increased expression levels of the liver residing fatty acid binding protein (Fabp1, Q3V2F7) indicate an active PPAR pathway [12] which, in turn, initiates adipose cell differentiation ultimately resulting in NAFLD [13].